Kuvan®'s Effect on the Cognition of Children With Phenylketonuria
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Phenylketonuria
Related studies linked through entity extraction aliases.
Protein Requirements in Children With Phenylketonuria (PKU)
- Status
- COMPLETED
- Phase
- NA
Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study
- Status
- COMPLETED
- Phase
- N/A
The Brain, Neurological Features and Neuropsychological Functioning in Adults With Phenylketonuria: A Pilot Study
- Status
- COMPLETED
- Phase
- NA
Moderate Intensity Exercise and Phenylketonuria
- Status
- TERMINATED
- Phase
- NA
Biological Variation of Phenylalanine in Patients With Hyperphenylalaninemia
- Status
- COMPLETED
- Phase
- N/A
An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165
- Status
- COMPLETED
- Phase
- PHASE3
Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria
- Status
- COMPLETED
- Phase
- PHASE3
Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria
- Status
- RECRUITING
- Phase
- NA
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
- Status
- COMPLETED
- Phase
- PHASE2
Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy
- Status
- TERMINATED
- Phase
- NA
Liver Cell Transplant for Phenylketonuria
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase 2 Study of Glycomacropeptide Versus Amino Acid Diet for Management of Phenylketonuria
- Status
- COMPLETED
- Phase
- NA
Phenylketonuria, Oxidative Stress, and BH4
- Status
- TERMINATED
- Phase
- PHASE2
Kuvan® in Phenylketonuria Patients Less Than 4 Years Old
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan Nonresponders
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Follow-up of Adult Phenylketonuria (PKU) Patients
- Status
- COMPLETED
- Phase
- N/A
Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period
- Status
- COMPLETED
- Phase
- PHASE4